课题基金 / 基金详情

Dynamics of Global Histone Acetylation in Regulating Intracellular pH

Dynamics of Global Histone Acetylation in Regulating Intracellular pH
整体组蛋白乙酰化在调节细胞内 pH 值中的动态
批准号:
8718883
负责人:
Narsis Attar
金额:
$3.58万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2017-05-31

项目摘要

项目成果

Narsis Attar的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):全球组蛋白乙酰化在癌症中的预后价值首先由我们小组描述,此后已由多个其他实验室独立验证。这些报告发现,在癌症组织中,组蛋白乙酰化水平较低与癌症相关的死亡率和发病率显著相关。然而,组蛋白乙酰化的全球变化及其与癌症生物学的相关性的功能和调节一直是完全未知的。最近,我们小组揭示了染色质和全局组蛋白乙酰化作为细胞内质子负荷调节器的新作用。我们已经证明,全局组蛋白去乙酰化与醋酸离子和质子通过单羧酸转运体(MCTs)共同运输出细胞相偶联,从而允许在酸性条件下调节细胞内的pH。相反,组蛋白在碱性pH下被全局乙酰化,通过隔离醋酸盐离子与细胞内可用质子共同运输出细胞来对抗细胞内pH的增加。组蛋白在低pH条件下的整体脱乙酰化需要持续的组蛋白脱乙酰酶(HDAC)活性,因为对组蛋白脱乙酰酶的药物抑制会影响在酸性微环境中的phi维持。这项建议旨在确定组蛋白乙酰化变化在全基因组范围内的准确分布,以响应细胞内pH的变化以及对基因表达和癌细胞行为的影响。我们将试图阐明pH诱导组蛋白去乙酰化的机制,并确定参与调控这一过程的主要HDACs。到目前为止,我们的数据表明,在癌症组织中,组蛋白乙酰化具有这种新的功能。我们推测,显示低组蛋白乙酰化水平的癌症组织可能正在利用这一机制来维持相对碱性的PHI,尽管细胞外环境是酸性的--这是众所周知的快速分裂细胞的标志。这项研究的结果将揭示染色质生物学和组蛋白乙酰化在整合基因表达控制和细胞生理学方面的一个新维度。此外,我们的工作将为在临床上更有效地使用HDAC抑制剂(HDACi)提供新的见解,并有可能揭示HDACi在各种类型癌症中的先天性和获得性耐药机制。
英文摘要
DESCRIPTION (provided by applicant): The prognostic value of global histone acetylation in cancer was first described by our group and has been since validated independently by multiple other laboratories. These reports have discovered that in cancer tissue, a lower global level of histone acetylation is significantly associated with cancer-related mortality and morbidity. However, the function and regulation of global changes in histone acetylation and its relevance to cancer biology had been completely unknown. Recently, our group has revealed a novel role of chromatin and global histone acetylation as a regulator of intracellular proton load. We have shown that global histone deacetylation is coupled to the co-transport of acetate ions and protons out of the cell through the monocarboxylate transporters (MCTs), allowing for regulation of intracellular pH in acidic conditions. Conversely, histones are globally acetylated at alkaline pH to combat the increase in intracellular pH by sequestering acetate ions from co-transport out of the cell with available intracellular protons. Global deacetylation of histones at low pH requires continuous histone deacetylase (HDAC) activity as pharmacological inhibition of HDACs compromises pHi maintenance in acidic microenvironments. This proposal aims to determine the precise genome-wide distribution of changes in histone acetylation in response to changes in intracellular pH and the consequences for gene expression and cancer cell behavior. We will seek to elucidate the mechanism of pH-induced histone deacetylation and identify the main HDACs involved in regulating this process. Our data thus far suggest the implication of this novel function of global histone acetylation in cancer tissues. We postulate that cancer tissues displaying low histone acetylation levels, may be utilizing this mechanism to maintain a relatively alkaline pHi despite an acidic extracellular environment-a well-known hallmark of rapidly dividing cells. The findings of this research will reveal a novel dimension of chromatin biology and histone acetylation in integrating control of gene expression with cellular physiology. Furthermore, our work will provide new insight into more effective use of HDAC inhibitors (HDACi) in the clinic and has the potential to shine light on mechanisms of HDACi innate and acquired resistance in various types of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynamics of Global Histone Acetylation in Regulating Intracellular pH
海外基金